Study title: A randomised , double blind, 3-Way Crossover study to compare the protective effect o single doses of an alternative propellanst (HFA-227) - Formulation of sodium Cromoglycate 2x5mg with Intal (Lomudal) MDI 2x5mg and HFA-227 placebo in asthmatic volunteer
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: MONTELUKAST | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: Study CR 2710 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |